Ian Richter, DPM
Foot & Ankle Surgery · Milford, CTNPI 1164983052
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Arthrex at 44.4% of the total. Reporting peaked in 2022 at $5,123 and has fallen 95.9% since, to $210 in 2025.
Across 71 payments — averaging $90.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Gramercy Extremity Orthopedics LLC$434
- Organogenesis Inc.$347
- Davol Inc.$283
- Bioventus LLC$213
- plus $1K from 19 others
What the payments were for
- Travel & lodging$1,33021%
- Food & beverage$2,72742%
- Education$2,40037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 13 | $2,870 |
| Gotham Surgical Solutions & Devices, Inc. | 7 | $1,239 |
| Gramercy Extremity Orthopedics LLC | 2 | $434 |
| Organogenesis Inc. | 10 | $347 |
| Davol Inc. | 3 | $283 |
| Bioventus LLC | 4 | $213 |
| Smith+Nephew | 4 | $203 |
| Heron Therapeutics, Inc. | 1 | $125 |
| Convatec Inc. | 2 | $121 |
| Hydrofera LLC | 2 | $111 |
| Paratek Pharmaceuticals, Inc. | 4 | $69 |
| Orthofix Medical, Inc. | 2 | $68 |
| Stryker | 3 | $67 |
| Integra Lifesciences Corporation | 2 | $51 |
| Medline Industries LP | 1 | $42 |
| Polynovo North America LLC | 2 | $38 |
| Curonix LLC | 1 | $31 |
| DJO, LLC | 1 | $29 |
| AbbVie | 1 | $25 |
| Treace Medical Concepts, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Kerecis Limited | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$247
- ARISTA AH FLEXITIP$159
- Exogen Ultrasound Bone Healing System$150
- Zynrelef$125
- Grafix$116
How this compares
$6,458 in reported general payments places this provider in the 75th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 21 | $511 |
| Clotrimazole | 15 | $416 |
| Ketoconazole | 29 | $316 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Milford
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
- Paulina PiekarskaNorwalk$13K
- Allen FerrucciHamden$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.